Management of Pregnancy-Induced Thrombocytopenia

Diagnostic Approach

Prior thrombocytopenia when not pregnant strongly suggests ITP rather than gestational thrombocytopenia, according to the American Society of Hematology 3
Timing matters critically: Thrombocytopenia in the first or second trimester raises suspicion for ITP or other pathology, while late third-trimester onset suggests gestational thrombocytopenia, as recommended by the American College of Obstetricians and Gynecologists 1, 2
Gestational thrombocytopenia characteristics: asymptomatic, mild (typically >70,000/μL, often 130,000-150,000/μL), occurs in late gestation, not associated with fetal thrombocytopenia, resolves spontaneously postpartum, as stated by the National Institutes of Health 3, 4, 5

Treat when platelet count <10,000/μL at any gestational age, even if asymptomatic, as recommended by the American Society of Hematology 1, 2
Treat when platelet count 10,000-30,000/μL with active bleeding, regardless of trimester, according to the American College of Obstetricians and Gynecologists 1, 2

Prednisone 10-20 mg/day is the recommended initial treatment, adjusted to the minimum dose that maintains hemostatic platelet counts, as stated by the National Institutes of Health 1, 2
IVIg is appropriate when corticosteroids are ineffective or cause significant side effects, as recommended by the American Society of Hematology 1

The mode of delivery should be determined by obstetric indications alone, not by maternal platelet count, according to the American College of Obstetricians and Gynecologists 1, 2
Transfuse platelets before delivery when maternal platelets <10,000/μL with planned cesarean section, as recommended by the American Society of Hematology 1, 2

Check cord blood platelet count at delivery by clean venepuncture of cord vessel, not by draining blood from cord, as stated by the National Institutes of Health 1
Monitor neonatal platelet counts for 3-4 days after birth, as counts typically nadir at 24-48 hours (days 2-5) after delivery, according to the American Academy of Pediatrics 1, 2
IVIg 1 g/kg is recommended for neonatal platelets <20,000/μL without evidence of intracranial hemorrhage, as recommended by the American Society of Hematology 1, 2

The neonatal mortality rate for babies born to mothers with ITP is less than 1%, with intracranial hemorrhage occurring in only 0-1.5% of thrombocytopenic infants, as stated by the National Institutes of Health 1
Fetal or neonatal platelet count cannot be reliably predicted by maternal platelet count, platelet antibody levels, or history of maternal splenectomy, according to the American College of Obstetricians and Gynecologists 1